Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ocular myasthenia gravis saccades as a measure of extraocular muscle function. | Front Ophthalmol (Lausanne) | 2022 | 38983530 | PubTator, text mining | PubMed |
| A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience. | Curr J Neurol | 2022 | 38011443 | PubTator, text mining | PubMed |
| [Cybersecurity of brain-computer interfaces]. | Int Cybersecur Law Rev | 2022 | 37521509 | PubTator, text mining | PubMed |
| Postpartum Myasthenic Crisis in a Patient with SLE: A Case Report and Literature Review. | Mediterr J Rheumatol | 2022 | 37034370 | PubTator, text mining | PubMed |
| Clinical spectrum of myasthenia gravis: An institute experience over 8 years from North East India. | J Family Med Prim Care | 2022 | 36993138 | PubTator, text mining | PubMed |
| New-Onset Myasthenia Gravis Following COVID-19 Vaccination. | Ann Indian Acad Neurol | 2022 | 36911477 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Bovine Macrophages (BoMac) Cells after Infection with Bovine Immunodeficiency Virus. | J Vet Res | 2022 | 36846036 | PubTator, text mining | PubMed |
| Multiple Cranial Neuropathies Similar to Orbital Apex Syndrome Associated with Pembrolizumab: A Case Report. | Case Rep Oncol | 2022 | 36825096 | PubTator, text mining | PubMed |
| Multiple skin neoplasms at one site (MUSK IN A NEST): collision tumor consisting of epidermal (macular seborrheic keratosis) and dermal (lichen amyloidosis) components. | Dermatol Online J | 2022 | 36809132 | PubTator, text mining | PubMed |
| Is paravertebral muscles edema a consequence of neurogenic changes in MuSK-positive myasthenia gravis? | Acta Myol | 2022 | 36793652 | PubTator, text mining | PubMed |
| A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection. | Cureus | 2022 | 36721575 | PubTator, text mining | PubMed |
| DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1. | Cancer Res Commun | 2022 | 36713812 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitor-induced myocarditis and myositis in liver cancer patients: A case report and literature review. | Front Oncol | 2022 | 36713559 | PubTator, text mining | PubMed |
| Different living environments drive deterministic microbial community assemblages in the gut of Alpine musk deer (Moschus chrysogaster). | Front Microbiol | 2022 | 36713154 | PubTator, text mining | PubMed |
| Reduced quality of life in myasthenia gravis patients: A study on 185 patients from China. | Front Neurol | 2022 | 36712441 | PubTator, text mining | PubMed |
| Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case-Control study. | Front Neurol | 2022 | 36712429 | PubTator, text mining | PubMed |
| D-penicillamine Induced Myasthenia Gravis in Wilson's Disease: A Case Report. | JNMA J Nepal Med Assoc | 2022 | 36705187 | PubTator, text mining | PubMed |
| Exploring the role of immune checkpoint inhibitors in the etiology of myasthenia gravis and Lambert-Eaton myasthenic syndrome: A systematic review. | Front Neurol | 2022 | 36698907 | PubTator, text mining | PubMed |
| Traditional Chinese medicine improves myasthenia gravis by regulating the symbiotic homeostasis of the intestinal microbiota and host. | Front Microbiol | 2022 | 36687653 | PubTator, text mining | PubMed |
| Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery. | Pharmaceutics | 2022 | 36678688 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=34